Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01635959

Acronym

GERD Q NIS

Enrollment

3170

Registered

2012-07-10

Start date

2012-07-31

Completion date

2014-07-31

Last updated

2014-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Upper Gastro-intestinal Symptoms

Keywords

upper gastro-intestinal symptoms, GERD

Brief summary

The purpose of this study is to calculate the prevalence of gastroesophageal reflux disease (GERD) by mean of GERD-Q questionnaire in patients with upper gastrointestinal tract symptoms in Egypt.

Detailed description

Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt

Interventions

None listed

Study design

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years and above * Attending the medical office and reporting symptoms suggestive of upper gastrointestinal tract symptoms such as heartburn/regurgitation, abdominal pain, bloating, belching and nausea/vomiting.

Exclusion criteria

* Participating on a clinical trial during the last 3 months. * Patients not able to read and/or understand the GERD-Q questionnaire. * Patients already included in the study in other participating site. * Patients taking PPIs or H2blockers in the l

Design outcomes

Primary

Measure	Time frame	Description
Percentage of patients scoring ≥ 8 in GERD-Q	baseline	Percentage of patients scoring ≥ 8 in GERD-Q will be considered as suffering from GERD. The GERD-Q is a potentially useful tool for family practitioners and other health care professionals in diagnosing and managing GERD without initial specialist referral or endoscopy. The Egyptian-validated version of the GERD-Q will be used for the study purposes.

Secondary

Measure	Time frame	Description
Socio-demographic characteristics of patients diagnosed with gastroesophageal reflux disease (GERD)	baseline	Descriptive analysis of socio-demographic characteristics of patients diagnosed with gastroesophageal reflux disease (GERD) in Egypt.
Treatment patterns in patients diagnosed with gastroesophageal reflux disease (GERD)	baseline	Descriptive analysis of treatment patterns in patients diagnosed with gastroesophageal reflux disease (GERD) in Egypt.

Countries

Egypt

Outcome results